Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2021
- The Future of Generics
Advertise

Search

Search

Close

Trending

Pfizer seeks to overturn three RSV vaccine patents held by GSK

Bayer launches digital AI platform for radiology specialists

Pfizer and Roivant launch autoimmune specialist Priovant

US panel backs Omicron-targeting vaccines for booster campaigns

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

Mission Therapeutics

Biotech 600

Articles/ Clinical/ UK & Europe/ Views and analysis

Will the UK ever produce a world-class biotech company?

Andrew McConaghie Biotech, Cambridge, F-star, Kymab, Mission Therapeutics, UK biotech 0 Comment

Kymab, F-star and Mission Therapeutics among crop of new UK biotechs.

X

Will the UK ever produce a world-class biotech company?

https://pharmaphorum.com/views-and-analysis/will-uk-ever-produce-world-class-biotech-company-2/

mission-therapeutics

Mission Therapeutics raises £60m to advance novel ‘DUB’ drug platform

Andrew McConaghie Mission Therapeutics, Prof Steve Jackson, UK biotech 0 Comment

UK biotech company Mission Therapeutics has raised £60 million to invest into its drug discovery and development programme.

X

Mission Therapeutics raises £60m to advance novel ‘DUB’ drug platform

https://pharmaphorum.com/news/mission-therapeutics-raises-60m-to-advance-novel-dub-drug-platform/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

Ipsen beefs up in oncology, buying US biopharma Epizyme
GSK hepatitis B hope bepirovirsen heads for phase 3 test
Novartis will shed 7% of workforce in restructuring, say reports
Gilead tries again with twice-yearly HIV drug lenacapavir
Another Astellas gene therapy hits a safety hurdle

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise
pharmaphorum connect

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com